Citation Impact
Citing Papers
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
2000 Standout
Early indicators of prognosis in fulminant hepatic failure
1989 Standout
Liver cell carcinoma
1989
Cryptochrome, Circadian Cycle, Cell Cycle Checkpoints, and Cancer
2005 StandoutNobel
EGFR Antagonists in Cancer Treatment
2008 Standout
Hepatocellular carcinoma
2003 Standout
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
Hepatitis C Virus Genotypes and Risk of Hepatocellular Carcinoma in Cirrhosis: A Prospective Study
1997
Fatal Autoimmune Hepatitis Induced by Concurrent Loss of Naturally Arising Regulatory T Cells and PD-1-Mediated Signaling
2008 StandoutNobel
Hepatitis C Virus Infection
2001 Standout
Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era
2008
R1 Resection by Necessity for Colorectal Liver Metastases
2008
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
1998 Standout
Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels
1998
Viral Dynamics of Hepatitis C Early After Orthotopic Liver Transplantation: Evidence for Rapid Turnover of Serum Virions
1996
Long-Term Outcome of Hepatitis C Infection after Liver Transplantation
1996
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Diagnosis and Management of Autoimmune Hepatitis
2010
HEPATITIS C VIRUS AND ORGAN TRANSPLANTATION
1996
Classification of Surgical Complications
2004 Standout
Drug-Induced Hepatotoxicity
2003 Standout
Hepatocellular carcinoma
2012 Standout
Hepatobiliary surgery
2000
Exposure to Cytomegalovirus from the Donated Organ Is a Risk Factor for Bacteremia in Orthotopic Liver Transplant Recipients
1996
Clinical Pharmacokinetics in Organ Transplant Patients
1989
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
2009 Standout
Oxaliplatin (L-OHP): a new reality in colorectal cancer
1998
Autoimmune Hepatitis, From Mechanisms to Therapy
2006
Gout
2009 Standout
Liver Transplantation in European Patients with the Hepatitis B Surface Antigen
1993
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
2004 Standout
Colorectal cancer prevention and treatment
2000
Colorectal cancer
2019 Standout
Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen
1998
Long-Term Results of Two-Stage Hepatectomy for Irresectable Colorectal Cancer Liver Metastases
2008
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
2004 Standout
Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection.
1996 StandoutNobel
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
1996 Standout
Priming of hepatitis C virus-specific cytotoxic t lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA
2000 StandoutNobel
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
2013 StandoutNobel
Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial
2007
American Gastroenterological Association Technical Review on the Management of Hepatitis C
2006
Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.
1995 StandoutNobel
Gout in Solid Organ Transplantation
2005
Is Liver Transplantation Justified for the Treatment of Hepatic Malignancies?
1990
Hepatitis C virus genotypes and quasispecies
1999
Influence of Preoperative Transarterial Lipiodol Chemoembolization on Resection and Transplantation for Hepatocellular Carcinoma in Patients With Cirrhosis
1997
Hepatitis C virus genotyping by means of 5′-UR/core line probe assays and molecular analysis of untypeable samples
1995
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
2007 StandoutNatureNobel
Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer
1997
The Role of Liver Transplantation in Hepatobiliary Malignancy. A Retrospective Analysis of 95 Patients with Particular Regard to Tumor Stage and Recurrence
1989
Progression of Alphafetoprotein Before Liver Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients: A Critical Factor
2009
Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial
2002 Standout
Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: A French survey of 6,664 patients
1997
Interferons α and λ Inhibit Hepatitis C Virus Replication With Distinct Signal Transduction and Gene Regulation Kinetics
2006 StandoutNobel
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
2008 Standout
European collaborative study on factors influencing outcome after liver transplantation for hepatitis C
1999
Infection in Solid-Organ Transplant Recipients
2007 Standout
Pathogenesis, diagnosis and management of hepatitis C
2000
Pharmacological Modulation of Cisplatin Toxicity Rhythms with Buthionine Sulfoximine in Mice Bearing Pancreatic Adenocarcinoma (PO3)
1998
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
2001 Standout
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 Standout
Variability of the Hepatitis C Virus Genome
1998
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
Infection in Organ-Transplant Recipients
1998 Standout
Transplantation of the liver in adults and children with fulminant hepatic failure
1988
Association of multispecific CD4+ response to hepatitis C and severity of recurrence after liver transplantation
1999 StandoutNobel
Definition and Classification of Negative Outcomes in Solid Organ Transplantation Application in Liver Transplantation
1994
Mathematical modeling of primary hepatitis C infection: Noncytolytic clearance and early blockage of virion production
2005 StandoutNobel
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Phase II Trial of Cetuximab in Combination With Fluorouracil, Leucovorin, and Oxaliplatin in the First-Line Treatment of Metastatic Colorectal Cancer
2007
Gout in liver transplant patients receiving tacrolimus
2004
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest
2007
Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status.
2000
Hepatitis C infection in the transplant recipient.
1995
Liver transplantation in the treatment of primary liver cancer.
1990
Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients
1991
Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer
2000
Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture
2003 StandoutNobel
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
1999 Standout
Viruses in Human Cancers
1991 StandoutScienceNobel
The Role of Clock Genes in Pharmacology
2010
Identification and characterization of autoantibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis.
1990 StandoutNobel
Phase I/II Trial of Capecitabine, Oxaliplatin, and Radiation for Rectal Cancer
2003
Autoimmune Hepatitis
2006
Circadian Clock, Cancer, and Chemotherapy
2014 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
LIVER TRANSPLANTATION FOR CHRONIC VIRAL HEPATITIS
1999
Treatment of Chronic Viral Hepatitis
1998
Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy
1998 StandoutScience
Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific Ligand
2012 StandoutNobel
Treatment of Chronic Viral Hepatitis
2001
HEPATITIS C INFECTION IN THE TRANSPLANT RECIPIENT
1995
Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis.
1988
Multicenter Phase II Study of Bimonthly High-Dose Leucovorin, Fluorouracil Infusion, and Oxaliplatin for Metastatic Colorectal Cancer Resistant to the Same Leucovorin and Fluorouracil Regimen
1999
Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatin.
1999
Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication
2004 StandoutNobel
Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine
2001 StandoutNobel
Works of H. Bismuth being referenced
Early Recovery of Albumin Synthesis after Liver Transplantation
1975
Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery
1999
Biweekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, fluorouracil, and leucovorin in patients with metastatic colorectal cancer.
1996
Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation
1995
Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease
1999
Serum uric acid and liver transplantation.
1995
Right portal vein embolization in preparation for major hepatic resection.
1995
HEPATIC TRANSPLANTATION IN EUROPE
1987
Risk factors for bacterial infection after liver transplantation.
1994
[Adult to adult living-related liver transplantation. The Paul-Brousse Hospital preliminary experience].
2001
157 Timing for liver transplantation in HIV coinfected patients
2004